$740 Million is the total value of Rhenman & Partners Asset Management AB's 95 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HAL | Halliburton Co (Hg Co) | $545,000 | +6.2% | 11,144 | 0.0% | 0.07% | +13.8% | |
XOM | Exxon Mobil Corp | $476,000 | +1.9% | 5,696 | 0.0% | 0.06% | +6.7% | |
MSFT | Microsoft Corp | $410,000 | +14.8% | 4,793 | 0.0% | 0.06% | +19.6% | |
PFE | Pfizer Inc | $377,000 | +1.3% | 10,422 | 0.0% | 0.05% | +8.5% | |
F | Ford Motor Co | $355,000 | +4.4% | 28,404 | 0.0% | 0.05% | +11.6% | |
QCOM | Qualcomm Inc | $344,000 | +23.7% | 5,368 | 0.0% | 0.05% | +31.4% | |
BUD | Anheuser-Busch InBev SA ADR spons repr 1 Sharesponsored adr | $313,000 | -6.6% | 2,806 | 0.0% | 0.04% | -2.3% | |
IBM | IBM Corp | $271,000 | +5.9% | 1,766 | 0.0% | 0.04% | +12.1% | |
SYMC | Symantec Corp | $263,000 | -14.3% | 9,359 | 0.0% | 0.04% | -7.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-19
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
ALKERMES PLC | 40 | Q3 2023 | 3.3% |
LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR/A | 2023-11-13 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.